Technical Analysis for CSTL - Castle Biosciences, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | N/A | Down | Up |
| See historical CSTL trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.20% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.20% | |
| Narrow Range Bar | Range Contraction | 0.20% | |
| NR7 | Range Contraction | 0.20% | |
| Multiple of Ten Bearish | Other | 0.20% | |
| Inside Day | Range Contraction | 0.20% | |
| Wide Bands | Range Expansion | 0.20% | |
| MACD Bullish Signal Line Cross | Bullish | -0.86% | |
| Multiple of Ten Bearish | Other | -0.86% | |
| Wide Bands | Range Expansion | -0.86% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Diagnostics & Research
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Medicine Health Cancer Clinical Medicine Medical Tests Gene Expression Melanoma Metastasis
Medicine Health Cancer Clinical Medicine Medical Tests Gene Expression Melanoma Metastasis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more CSTL news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 28.5 |
| 52 Week Low | 16.78 |
| Average Volume | 126,951 |
| 200-Day Moving Average | 0.0 |
| 50-Day Moving Average | 21.5518 |
| 20-Day Moving Average | 20.047 |
| 10-Day Moving Average | 18.739 |
| Average True Range | 1.5965 |
| ADX | 27.85 |
| +DI | 16.4687 |
| -DI | 23.6688 |
| Chandelier Exit (Long, 3 ATRs ) | 19.3705 |
| Chandelier Exit (Short, 3 ATRs ) | 21.5695 |
| Upper Bollinger Band | 23.6272 |
| Lower Bollinger Band | 16.4668 |
| Percent B (%b) | 0.45 |
| BandWidth | 35.718063 |
| MACD Line | -0.8701 |
| MACD Signal Line | -0.9506 |
| MACD Histogram | 0.0804 |
| Fundamentals | Value |
|---|---|
| Market Cap | 78.92 Thousand |
| Num Shares | 4.01 Thousand |
| EPS | 0.15 |
| Price-to-Earnings (P/E) Ratio | 132.01 |
| Price-to-Sales | 1.19 |
| Price-to-Book | 1.38 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 20.57 | ||||
| Resistance 3 (R3) | 20.61 | 20.34 | 20.42 | ||
| Resistance 2 (R2) | 20.34 | 20.11 | 20.33 | 20.37 | |
| Resistance 1 (R1) | 20.01 | 19.97 | 19.88 | 19.97 | 20.32 |
| Pivot Point | 19.74 | 19.74 | 19.68 | 19.73 | 19.74 |
| Support 1 (S1) | 19.41 | 19.51 | 19.28 | 19.37 | 19.02 |
| Support 2 (S2) | 19.14 | 19.37 | 19.13 | 18.97 | |
| Support 3 (S3) | 18.81 | 19.14 | 18.92 | ||
| Support 4 (S4) | 18.77 |
